Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis David Afshartous,

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant Ji Lee, PharmD, Peace Imani, MD, Jessica Geer, C-PNP, Michael Braun, MD,

Renal Function Testing

Peritoneal dialysis American Journal of Kidney Diseases

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Phosphate Kinetic Models in Hemodialysis: A Systematic Review

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Care of the Undocumented Immigrant in the United States With ESRD

Peripherally Inserted Central Catheters and Other Intravascular Devices: How Safe Are They for Hemodialysis Patients? Roman Shingarev, MD, Michael Allon,

Quiz Page March 2008 American Journal of Kidney Diseases

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

Impact of Comorbidities on Mortality in Managed Care Patients With CKD

Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis Matthew S. Shotwell, PhD, Phillip.

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Evaluation of the Potential Living Kidney Donor

Kidney Tattoos American Journal of Kidney Diseases

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Karl D. Nolph, MD, American Journal of Kidney Diseases

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Iva Gunnarsson, MD, PhD American Journal of Kidney Diseases

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Nosratola D. Vaziri, MD American Journal of Kidney Diseases

Abdominal Compartment Syndrome and Acute Kidney Injury Due to Excessive Auto– Positive End-Expiratory Pressure Dwight Matthew, MD, David Oxman, MD, Karim.

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Julie A. Wright Nunes, MD, MPH, Kerri L

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo.

Polyunsaturated Fatty Acids and Kidney Disease

Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.

Salicylate Intoxication as a Cause of Pseudohyperchloremia

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Fabry Disease: A Rare Cause of Fever of Unknown Origin

Drug Dose Adjustments in Patients With Renal Impairment

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Erratum American Journal of Kidney Diseases

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Trial Quality in Nephrology: How Are We Measuring Up?

Kim Dao, MD, Haithem Chtioui, MD, Yimin Lu, MD, Cody J

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Making Music American Journal of Kidney Diseases

Erratum American Journal of Kidney Diseases

In the Literature: Cognitive Impairment in Hemodialysis Patients

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Quiz Page June 2009 American Journal of Kidney Diseases

Supportive care for patients with renal disease: Time for action

Quiz Page June 2011 American Journal of Kidney Diseases

Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD

This Month in AJKD American Journal of Kidney Diseases

How to Manage Functional Vitamin K Deficiency in CKD

Increased Plasma Levels of Tacrolimus After Ingestion of Green Tea

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Maristela Böhlke, PhD American Journal of Kidney Diseases

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Phosphate Balance in Continuous Venovenous Hemofiltration

Presentation transcript:

Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis David Afshartous, PhD, Seth R. Bauer, PharmD, Michael J. Connor, MD, Olufemi A. Aduroja, MD, Milen Amde, MD, Charbel Salem, MD, Joseph J. Groszek, William H. Fissell, MD American Journal of Kidney Diseases Volume 63, Issue 1, Pages 170-171 (January 2014) DOI: 10.1053/j.ajkd.2013.08.015 Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Distribution of fractional time plasma concentration was >8 μg/mL (4×MIC for susceptible bacteria). Drug exposure as estimated by this metric varied widely between individuals. American Journal of Kidney Diseases 2014 63, 170-171DOI: (10.1053/j.ajkd.2013.08.015) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions